Overview of Dr. Muranski
Dr. Pawel Muranski is a hematologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from Medical University of Warsaw and has been in practice 22 years. He is one of 26 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center and one of 64 doctors at New York-Presbyterian Hospital who specialize in Hematology. He has more than 70 publications and over 500 citings.
Office
161 Fort Washington Avenue
New York, NY 10032
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology, 2003 - 2006
Medical University of WarsawClass of 1996
Certifications & Licensure
NY State Medical License 2017 - 2025
IL State Medical License 2002 - 2020- American Board of Internal Medicine Hematology
Clinical Trials
- Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections Start of enrollment: 2014 Sep 03
- R-MVST Cells for Treatment of Viral Infections Start of enrollment: 2022 May 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsVirus-specific T cell therapy to treat refractory viral infections in solid organ transplant recipients.Lorne Schweitzer, Pawel Muranski
American Journal of Transplantation. 2024-09-01 - 3 citationsAntiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II intervent...Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak
Nature Communications. 2024-04-18 - 3 citationsImmune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV.Andrea Lisco, Camille Lange, Maura Manion, Safia Kuriakose, Robin Dewar
Nature Medicine. 2023-06-01
Press Mentions
“Living Drug” Created by Columbia Immunologists May Save Transplanted OrgansDecember 9th, 2022- Are Immunocompromised Patients Left Out by COVID Vaccines?July 26th, 2021
- Shop TalkNovember 10th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
